Target intelligence / Profile preview

Deoxyribonucleic acid in tumor cell nucleus (DNA)

Target
DNA
Molecular classification
Genetic material, Nucleic acid
01

Overview

DNA in the tumor cell nucleus is the genetic material that contains the blueprint for all cellular functions and is a critical therapeutic target in cancer treatment. Located within the nucleus, which serves as the control center of the cell, DNA is organized into chromosomes and contains approximately 25,000 genes in humans[5][7]. In tumor cells, DNA often exhibits mutations and structural alterations that drive cancer development and progression. The nucleus is surrounded by a double membrane called the nuclear envelope, which separates the nucleoplasm from the cytoplasm and regulates the trafficking of molecules between these compartments[1][3]. This compartmentalization allows for controlled gene expression and prevents translation of unspliced mRNA[5]. Within the nucleus, DNA is typically found as chromatin, a loosely contained structure where DNA is wound around histone proteins[6]. Cancer development is frequently associated with mutations in specific types of genes within the nuclear DNA. These include oncogenes, which when activated promote excessive cell growth; tumor suppressor genes like p53, which when damaged fail to stop abnormal cell growth; DNA repair genes, whose dysfunction leads to accumulation of mutations; and self-destruction genes that regulate apoptosis[7][8]. Mutations in these genes can result from deletions, translocations, or small defects in the DNA sequence[8]. The altered nuclear DNA in tumor cells can affect nuclear mechanics and promote metastatic processes. Changes in nuclear envelope composition and chromatin organization can increase nuclear deformability, potentially benefiting metastatic cells that need to pass through narrow spaces[1]. Additionally, defects in the connections between the nucleus and cytoskeleton (the LINC complex) may impact cell migration and contribute to cancer progression[3]. As a therapeutic target, DNA in tumor cell nucleus is the focus of various cancer treatments that aim to damage DNA, inhibit its replication, or interfere with DNA repair mechanisms specifically in cancer cells while minimizing effects on healthy cells.

Other names
Nuclear DNAGenomic DNAChromosomal DNATumor cell DNA
02

Mechanism of action

DNA damage induction; Inhibition of DNA replication; Disruption of DNA repair mechanisms; Interference with gene expression

03

Biological functions

Gene expression regulationCell compartmentalizationDNA replicationProtein synthesis controlCell cycle controlApoptosis regulation
04

Disease associations

CancerMetastasisGenomic instabilityTumor progression
05

Safety considerations

Off-target DNA damage in healthy cellsDevelopment of resistance mechanismsGenomic instability leading to secondary malignanciesDifficulty in selective targeting of tumor cell DNA
06

Interacting drugs

DNA-targeting chemotherapeutics

3 more in the full profile.

07

Biomarkers

Mutations in tumor suppressor genes (e.g., p53)DNA repair gene defectsOncogene activationChromosomal abnormalities

Beyond the preview

Go deeper on Deoxyribonucleic acid in tumor cell nucleus (DNA).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Deoxyribonucleic acid in tumor cell nucleus (DNA).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call